InconclusiveDouble Blind Clinical Trial2021
A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures
Classification Results
AI Classification
InconclusiveFine-tuned Classification
N/A